Efferent Labs, Inc.

Efferent Labs® offers a live, cellular data acquisition platform that will radically alter the landscape of preclinical research. Our flexible platform technology, CytoComm®, allows the researcher to prescribe the target of interest. The sensor platform is then implanted within an animal, providing real-time molecular level data that has until now, been unobtainable. The ability for the CytoComm® platform to be easily tailored to the target of interest provides an extremely valuable tool in preclinical research.